NKTR
Nektar Therapeutics
$56.63
+$2.29(+4.21%)
54
Overall
40
Value
63
Tech
60
Quality
Market Cap
$1.05B
Volume
331.37K
52W Range
$6.45 - $62.95
Target Price
$104.50
EPS Estimates Overview
| Current Quarter | $-2.95 | Next Quarter | $-3.06 |
| Current Year | $-12.17 | Next Year | $-12.95 |
| QoQ Growth | -3.7% | YoY Growth | -6.4% |
| 3Y EPS CAGR | +76.2% | Target Price | $104.50 |
| Consensus | Buy | Upside | +84.5% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NKTR | $56.63 | +4.2% | 331.37K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |